MGMT and neoplasm: We identified 7 mutations of interest―including somatic SNVs in BRCA2, TGFBR2, FGFR1 and germline SNPs in SPTA1, MGMT. These mutations were identified using matched bulk tumor and normal sequencing data and were present in the single-cell data with high confidence (details in “Methods” section).